ArticlePloS one2026

Correction: Evaluating the pentapharmacological potency of otamixaban against lung cancer CDK2, transferase, oxidoreductase and signalling proteins.

Hanadi M Baeissa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.